JW (Cayman) Therapeutics Co. Ltd — Form D

JW (Cayman) Therapeutics Co. Ltd of Shanghai, F4, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-15. The offering totals $105.5M, of which $105.5M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-07-15
Form: D
Accession: 0001817872-20-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $105.5M
Amount sold: $105.5M
Investors: 2
Date of first sale: 2020-06-30
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-371020

Issuer

Name: JW (Cayman) Therapeutics Co. Ltd
CIK: 0001817872
Entity type: Other
Jurisdiction: CAYMAN ISLANDS
Incorporated: 2017
Address: 4560 Jinke Road, Floor 2, Bldg. 3, Shanghai, F4, 201210
Phone: 86-18516251949

Officers, directors & promoters (15)

Name	Role	Location
Hans Edgar Bishop	Director	Shanghai, F4
Yanling Edgar Cao	Director	Shanghai, F4
Xing Edgar Gao	Director	Shanghai, F4
Ann Li Edgar Lee	Director	Shanghai, F4
Yiping James Li	Director	Shanghai, F4
Cheng Edgar Liu	Director	Shanghai, F4
Jingwen Edgar Miao	Director	Shanghai, F4
Krishna Edgar Viswanadhan	Director	Shanghai, F4
Jinyin Edgar Wang	Director	Shanghai, F4
Yunxia Edgar Yang	Director	Shanghai, F4
Xin Edgar Fu	Executive Officer	Shanghai, F4
Harry Edgar Lam	Executive Officer	Shanghai, F4
Yiping James Li	Executive Officer	Shanghai, F4
Wenjun Edgar Sun	Executive Officer	Shanghai, F4
Hongxia Edgar Zheng	Executive Officer	Shanghai, F4

More